Dose Finding Phase 1 Study of the Treatment of Recurrent/Relapsed Glioblastoma Multiforme With MPC-6827 in Combination With Carboplatin.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Mar 2011
At a glance
- Drugs Carboplatin; Verubulin
- Indications Glioblastoma
- Focus Adverse reactions
- Sponsors Myrexis
- 24 Mar 2011 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 28 May 2010 Updated information on this trial will be presented as a poster at ASCO 2010, according to a Myriad Pharmaceuticals media release.
- 20 May 2010 19 patients have been accrued to this study as at 7 December 2009, according to a Myriad Pharmaceuticals media release.